Reza Fathi
Chief Tech/Sci/R&D Officer at REDHILL BIOPHARMA LTD.
Net worth: 74 913 $ as of 29/04/2024
Reza Fathi active positions
| Companies | Position | Start | End |
|---|---|---|---|
| REDHILL BIOPHARMA LTD. | Chief Tech/Sci/R&D Officer | 30/04/2010 | - |
Career history of Reza Fathi
Former positions of Reza Fathi
| Companies | Position | Start | End |
|---|---|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Chief Tech/Sci/R&D Officer | 31/12/2004 | - |
VivoQuest, Inc.
 VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Chief Operating Officer | 31/12/1999 | - |
| Chief Tech/Sci/R&D Officer | 31/12/1999 | - | |
| Harvard Medical School | Corporate Officer/Principal | 31/12/1997 | 31/12/1999 |
PharmaGenics, Inc.
 PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Corporate Officer/Principal | 31/12/1990 | 31/12/1997 |
Training of Reza Fathi
| Rutgers State University of New Jersey | Doctorate Degree |
| Texas Tech University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Israel | 3 |
| France | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| REDHILL BIOPHARMA LTD. | Health Technology |
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| Private companies | 2 |
|---|---|
VivoQuest, Inc.
VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Health Technology |
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Commercial Services |
- Stock Market
- Insiders
- Reza Fathi
- Experience
